Dose-response relationship of recent antidepressants in the short-term treatment of depression
Open accessAbstract
Antidepressant drugs are widely recommended for the treatment of depressive disorders, and finding the "right dose for the right patient" is an important issue. Whatever antidepressant is prescribed, a proportion of adult patients with major depression fail to respond satisfactorily to adequate first-line treatment. A frequent strategy for patients with insufficient response to an initial antidepressant dose is to increase the dose. This review is about this strategy, ie, the possible benefits of prescribing higher doses of recent antidepressants. The results show that a flat dose-response curve is a class phenomenon for selective serotonin reuptake inhibitors (SSRIs), according to randomized, controlled, fixed-dose clinical trials. For the serotonin and noradrenaline reuptake inhibitors (SNRIs), the strategy of dose increase may be relevant for venlafaxine, in order to increase the number of responders. Thus, the subgroup of patients for whom high doses of SSRIs could be useful remains to be defined.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Different doses of antidepressants might produce different treatment effects.
“Sixth, antidepressants with different doses might produce different treatment effects.41”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410 · see citing works
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373 · see citing works
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127 · see citing works
Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients
Burke, W. J., Gergel, I. P., & Bose, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0410 · Cited by 352 · see citing works
Evidence of the dual mechanisms of action of venlafaxine
Harvey, A. T., Rudolph, R. L., & Preskorn, S. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.503 · Cited by 302 · cited 1× · see citing works
“For venlafaxine, 5-HT and NA reuptake inhibition were demonstrated to be sequentially engaged according to the dose.(46) The four clinical trials at fixed doses that have evaluated the dose–response relationship of milnacipran in the treatment of major depression suggests that the dose–response curve is flat (Table II…”
MethodBollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.297 · Cited by 274 · see citing works
Identification of True Drug Response to Antidepressants
Quitkin, F. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190056007 · Cited by 221 · see citing works
Partial Response and Nonresponse to Antidepressant Therapy
Hirschfeld, R. M. A., Montgomery, S., Aguglia, E., Amore, M., Delgado, P. L., Gastpar, M., Hawley, C. J., Kasper, S. F., Linden, M., Massana, J., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0913 · Cited by 193 · see citing works
Use of Pattern Analysis to Identify True Drug Response
Quitkin, F. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150071009 · Cited by 191 · see citing works
Fabre, L. F., Abuzzahab, F. S., Amin, M., Claghorn, J. L., MENDELS, J., Petrie, W. M., Dubé, S., & Small, J. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00178-8 · Cited by 184 · see citing works
Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression
Feighner, J. P., & Overø, K. F. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1204 · Cited by 169 · see citing works
Montgomery, S., Rasmussen, J., & Tanghøj, P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00008 · Cited by 165 · see citing works
Fredman, S. J., D, M. F. M., Kienke, A. S., White, C. N., Nierenberg, A. A., & Rosenbaum, J. F. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0602 · Cited by 133 · see citing works
Rudolph, R. L., Fabre, L. F., Feighner, J. P., Rickels, K., Entsuah, R., & Derivan, A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0305 · Cited by 132 · see citing works
Fixed-dose fluoxetine therapy for depression.
Jf, W., Dunlop, S. R., Dornseif, B. E., & Zerbe, R. L. (1987) · PubMed · Cited by 120 · see citing works
Placebo-Controlled Trial of Venlafaxine for the Treatment of Major Depression
Schweizer, E. E., Weise, C., Clary, C. M., Fox, I., & Rickels, K. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199108000-00002 · Cited by 119 · see citing works
Antidepressant drug selection: criteria and options.
Preskorn, S. (1994) · PubMed · Cited by 115 · see citing works
Berzewski, H., Moffaert, M. V., & Gagiano, C. A. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00418-5 · Cited by 114 · see citing works
Optimal dose regimen for paroxetine.
Dünner, D. L., & Dunbar, G. C. (1992) · PubMed · Cited by 108 · see citing works
Chronological Milestones to Guide Drug Change
Quitkin, F. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090031005 · Cited by 107 · see citing works
Low-dose fluoxetine therapy for depression.
Wernicke, J. F., Dunlop, S. R., Dornseif, B. E., Bosomworth, J. C., & Humbert, M. (1988) · PubMed · Cited by 101 · see citing works
What constitutes an adequate antidepressant trial for fluoxetine?
Schweizer, E. E., Rickels, K., Amsterdam, J. D., Fox, I., Puzzuoli, G., & Weise, C. C. (1990) · PubMed · Cited by 100 · see citing works
Bech, P., Tanghøj, P., Andersen, H. F., & Overø, K. F. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1147-6 · Cited by 91 · see citing works
Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
MENDELS, J., Johnston, R. B., Mattes, J. A., & Riesenberg, R. A. (1993) · PubMed · Cited by 80 · see citing works
Khan, A., Upton, G. V., Rudolph, R. L., et al. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00004 · Cited by 77 · see citing works
Bech, P., Tanghøj, P., Cialdella, P., Andersen, H. F., & Pedersen, A. G. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004365 · Cited by 74 · see citing works
Ansseau, M., von Frenckell, R., Mertens, C., Wilde, J. D., Botte, L., Devoitille, J.-M., Evrard, J.-L., Nayer, A. D., Darimont, P., Dejaiffe, G., et al. (1989) · Psychopharmacology · doi:10.1007/bf00444686 · Cited by 72 · see citing works
The optimal dosing regimen for citalopram-a meta-analysis of nine placebo-controlled studies
Montgomery, S., Pedersen, V. M., Tanghøj, P., Rasmussen, C., & Rioux, P. P. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00006 · Cited by 67 · see citing works
Venlafaxine in depressed outpatients.
Khan, A., Lf, F., & Rudolph, R. L. (1991) · PubMed · Cited by 66 · see citing works
Efficacy issues with antidepressants.
FAWCETT, J. A., & Barkin, R. L. (1997) · PubMed · Cited by 65 · see citing works
Effect of dose escalation after low-dose fluoxetine therapy.
Dornseif, B. E., Dunlop, S. R., Jh, P., & Jf, W. (1989) · PubMed · Cited by 64 · see citing works
Time course of clinical response to venlafaxine: relevance of plasma level and chirality
Gex‐Fabry, M., Balant-Gorgia, A. E., Balant, L. P., Rudaz, S. L., Veuthey, J., & Bertschy, G. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0710-3 · Cited by 63 · see citing works
Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
Dunlop, S. R., Dornseif, B. E., Wernicke, J., & Potvin, J. H. (1990) · PubMed · Cited by 59 · see citing works
Clinical efficacy of milnacipran
Lecrubier, Y., Plétan, Y., Solles, A., Tournoux, A., & Magne, V. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609004-00004 · Cited by 57 · see citing works
Guelfi, J., Ansseau, M., Corruble, E., Samuelian, J., Tonelli, I., Tournoux, A., & Plétan, Y. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199805000-00005 · Cited by 56 · see citing works
Bjerkenstedt, L., Edman, G., Flyckt, L., et al. (1985) · Psychopharmacology · doi:10.1007/bf00432703 · Cited by 53 · see citing works
A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
Fabre, L. F., & Putman, H. P. (1987) · PubMed · Cited by 48 · see citing works
Dose-Response Relationship With Venlafaxine
Kelsey, J. E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606002-00005 · Cited by 48 · see citing works
Walczak, D. D., Apter, J. T., Halikas, J. A., Borison, R. L., Carman, J. S., Post, G., PATRICK, R. O., Cohn, J. N., Cunningham, L. A., Rittberg, B. R., et al. (1996) · Annals of Clinical Psychiatry · doi:10.3109/10401239609147751 · Cited by 47 · see citing works
Montgomery, S., RASMUSSEN, J. G. C., Lyby, K., CONNOR, P., & TANGHOSJ, P. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206005-00007 · Cited by 46 · see citing works
Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients
Bouchard, J. M., Delaunay, J., Delisle, J. ‐., Grasset, N., Mermberg, P. F., Molczadzki, M., Pagot, R., Richou, H., Robert, G., Ropert, R., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02923.x · Cited by 46 · see citing works
A double-blind, placebo-controlled dose-finding study with sertraline.
Amin, M., Lehmann, H., & Mirmiran, J. (1989) · PubMed · Cited by 42 · see citing works
Baker, C. B., Tweedie, R. L., Duval, S., & Woods, S. W. (2003) · Depression and Anxiety · doi:10.1002/da.10079 · Cited by 42 · see citing works
Benkert, O., Szegedi, A., Wetzel, H., Staab, H. J., Meister, W., & Philipp, M. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09634.x · Cited by 39 · see citing works
Fawcett, R. G. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0307d · Cited by 38 · see citing works
Interest of a loading dose of milnacipran in endogenous depressive inpatients
Ansseau, M., von Frenckell, R., Gérard, M.-A., Mertens, C., Wilde, J. D., Botte, L., Devoitille, J.-M., Evrard, J.-L., Nayer, A. D., Darimont, P., et al. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90712-4 · Cited by 25 · see citing works
Beasley, C. M., Bosomworth, J. C., & Wernicke, J. F. (1990) · PubMed · Cited by 20 · see citing works
Double‐blind dose determination study of a new antidepressant—sertraline
Guy, W., Manov, G., & Wilson, W. H. (1986) · Drug Development Research · doi:10.1002/ddr.430090404 · Cited by 13 · see citing works
[Is there a relationship between clinical efficacy and antidepressant dosage in major depression?].
Corruble, E., & Guelfi, J. D. (1999) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhou, X., Teng, T., Zhang, Y., Del Giovane, C., Furukawa, T. A., Weisz, J. R., Li, X., Cuijpers, P., Coghill, D., Xiang, Y., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30137-1 · Cited by 367 · see citing works
Hieronymus, F., Nilsson, S., & Eriksson, E. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.104 · Cited by 100 · see citing works
Cheng, Q., Huang, J., Xu, L., Li, Y., Li, H., Shen, Y., Zheng, Q., & Li, L. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz062 · Cited by 38 · see citing works
Safer, D. J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000564 · Cited by 19 · see citing works
- Authors
- Berney, P.
- Affiliations
- University Hospital of Geneva (CH)
- Corresponding author
- Berney, Patricia
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2005-09-30
- Volume
- 7
- Issue
- 3
- Pages
- 249-262
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC3181733
- OpenAlex
- W192041726
- Cited by
- 39
- References
- 51
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 6 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Keywords
- antidepressants, dose-response relationship, major depressive disorder, dose escalation, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, venlafaxine, antidepressant response, treatment-resistant depression
- MeSH terms
- Adult, Antidepressive Agents, Depression, Dose-Response Relationship, Drug, Humans, Time Factors, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
